Apart from HF hospitalization and all‐cause mortality, changes in NYHA functional class, LVEF, and NT‐proBNP levels before and after initiation of sacubitril/valsartan were also assessed in many real‐world studies. The gene discussed is NPPB; the disease is hydrops fetalis.